Comment on “Association of Intraoperative Red Blood Cell Transfusions With Venous Thromboembolism and Adverse Outcomes After Cardiac Surgery”

[1]  Ashish S. Shah,et al.  Association of Intraoperative Red Blood Cell Transfusions With Venous Thromboembolism and Adverse Outcomes After Cardiac Surgery , 2022, Annals of surgery.

[2]  Y. Kanthi,et al.  Inflammation, Infection and Venous Thromboembolism. , 2021, Circulation research.

[3]  Jing Liu,et al.  Risk of massive blood product requirement in cardiac surgery , 2019, Medicine.

[4]  Melissa Nichols,et al.  Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies. , 2016, Journal of the American College of Cardiology.

[5]  P. Mintz,et al.  Clotting factor product administration and same‐day occurrence of thrombotic events, as recorded in a large healthcare database during 2008–2013 , 2015, Journal of thrombosis and haemostasis : JTH.

[6]  P. V. D. van der Starre,et al.  Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery. , 2014, Journal of cardiothoracic and vascular anesthesia.

[7]  John B Carlin,et al.  American Journal of Epidemiology Practice of Epidemiology Multiple Imputation for Missing Data: Fully Conditional Specification versus Multivariate Normal Imputation , 2022 .

[8]  S. van Buuren.  Multiple imputation of discrete and continuous data by fully conditional specification , 2007, Statistical methods in medical research.

[9]  C. Fonner,et al.  Variation in Red Blood Cell Transfusion Practices During Cardiac Operations Among Centers in Maryland: Results From a State Quality-Improvement Collaborative. , 2017, The Annals of thoracic surgery.